Therapeutic Advances in Chronic Disease · 2020 · 56 citations · 27 references
In general, scutellarein might exert therapeutic effects on pulmonary fibrosis by altering the differentiation, proliferation, and apoptosis of fibroblasts. Although scutellarein has been demonstrated to be safe in mice, further studies are required to investigate the efficacy of scutellarein in patients with IPF.
27
Fibrotic microtissue array to predict anti-fibrosis drug efficacy
Mohammadnabi Asmani, Sanjana Velumani, Yan Li et al. · Nature Communications · 2018 · 137 citations · Full text
Yi Wang, Jianghui Zhu, Lei Zhang et al. · Journal of Allergy and Clinical Immunology · 2017 · 94 citations